trihexyphenidyl has been researched along with Blood Protein Disorders in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Blood Protein Disorders: Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diebold, J | 1 |
| James, JM | 1 |
| Dao, C | 1 |
| Reynes, M | 1 |
| Mignot, L | 1 |
| Tricot, G | 1 |
| Audouin, J | 1 |
| Bilski Pasquier, G | 1 |
1 other study available for trihexyphenidyl and Blood Protein Disorders
| Article | Year |
|---|---|
[Immunoblastic lymphoid hyperplasia resembling a tumour, due to drug hypersensitivity (author's transl)].
Topics: Blood Protein Disorders; Blood Vessels; Drug Hypersensitivity; Humans; Hyperplasia; Levodopa; Lympha | 1976 |